MFC Urges Trump Administration to Maintain Restrictions on Abortifacients During Pandemic
Thirty-two Family Policy Council directors across the nation, including Minnesota Family council CEO John Helmberger, have issued a letter to the U.S. Department of Health and Human Services (DHHS) and the U.S. Food & Drug Administration (FDA) urging them to uphold the current policy restricting telehealth doctors from prescribing chemical abortion drugs. This letter comes in response to a separate letter that was submitted by twenty-one state attorneys general—including Minnesota’s AG Keith Ellison—to DHHS Secretary Azar and FDA Commissioner Hahn, asking for loosened restrictions on mifepristone, the drug that causes an abortion by starving a developing baby of a critical hormone called progesterone.
In light of the COVID-19 pandemic, abortion activists have called for lifting of the FDA’s Risk Evaluation and Mitigation Strategy (REMS), which prevents mifepristone from being prescribed via a telehealth consultation with an abortionist. These activists argue “the REMS create unnecessary delays for women who need access to time-sensitive healthcare and force them to travel unnecessarily.” During this pandemic, our nation’s healthcare system has labored to serve and heal its citizens, and doctors have expanded telehealth services to achieve this goal. But lifting this REMS restriction would mean that women do not have to leave their homes in order to procure drugs for an abortion, and, as the FPC directors argue in their letter, this would have disastrous implications.